UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Understory Vegetation Responses to 15 Years of Repeated Fuel Reduction Treatments in the Southern Appalachian Mountains, USA

Forests, 2019-04, Vol.10 (4), p.350

2019

Volltextzugriff (PDF)

Identification of a serum-detectable metabolomic fingerprint potentially correlated with the presence of micrometastatic disease in early breast cancer patients at varying risks of disease relapse by traditional prognostic methods

Annals of oncology, 2011-06, Vol.22 (6), p.1295-1301

2011

Volltextzugriff (PDF)

19 Breast Cancer in the Elderly

European journal of cancer (1990), 2012-03, Vol.48, p.S46-S46

2012

Volltextzugriff (PDF)

Evaluation of the cardiovascular health study (CHS) instrument and the Vulnerable Elders Survey-13 (VES-13) in elderly cancer patients. Are we still missing the right screening tool?

Annals of oncology, 2013-02, Vol.24 (2), p.494-500

2013

Volltextzugriff (PDF)

225 INVITED EUSOMA Recommendations for the Management of Elderly Women With Breast Cancer

European journal of cancer (1990), 2011, Vol.47, p.S54-S54

2011

Volltextzugriff (PDF)

‘Aussie normals’: an a priori study to develop clinical chemistry reference intervals in a healthy Australian population

Pathology, 2015-02, Vol.47 (2), p.138-144

2015

Volltextzugriff (PDF)

209 Can we select patients for adjuvant therapy based on the presence of micro-metastatic disease?

European journal of cancer supplements, 2010, Vol.8 (3), p.120-120

Oakman, C

2010

Volltextzugriff (PDF)

Overall survival benefit for sequential doxorubicin–docetaxel compared with concurrent doxorubicin and docetaxel in node-positive breast cancer—8-year results of the Breast International Group 02-98 phase III trial

Annals of oncology, 2013-05, Vol.24 (5), p.1203-1211

2013

Volltextzugriff (PDF)

Chemotherapy with or without trastuzumab

Annals of oncology, 2010-10, Vol.21 (suppl-7), p.vii112-vii119

2010

Volltextzugriff (PDF)

Understory community shifts in response to repeated fire and fire surrogate treatments in the southern Appalachian Mountains, USA

Fire ecology, 2021-03, Vol.17 (1), Article 7

2021

Volltextzugriff (PDF)

Posthurricane Salinity in an Impounded Coastal Wetland (Bayou Sauvage, Louisiana, U.S.A.)

Journal of coastal research, 2019-09, Vol.35 (5), p.1003

2019

Volltextzugriff (PDF)

762 Prognostic and Predictive Value of TP53 Mutations in Node-positive Breast Cancer Patients Treated with Anthracycline-or Anthracycline/taxane Based Adjuvant Therapy – Results From the BIG 02-98 Phase III Trial

European journal of cancer (1990), 2012-07, Vol.48, p.S180-S181

2012

Volltextzugriff (PDF)

Palbociclib in Hormone-Receptor–Positive Advanced Breast Cancer

The New England journal of medicine, 2015-07, Vol.373 (3), p.209-219

2015

Volltextzugriff (PDF)

Other targets beyond PARP for TN disease

Breast (Edinburgh), 2011-10, Vol.20, p.S17-S17

2011

Volltextzugriff (PDF)

S4 Did we learn more about adjuvant chemotherapy? The dark side of data from clinical trials

Breast (Edinburgh), 2009, Vol.18, p.S2-S2

2009

Volltextzugriff (PDF)

Preoperative investigations for metastatic staging of colon and rectal cancer across multiple centres - what is current practice?

Colorectal disease, 2009-07, Vol.11 (6), p.592-600

2009

Volltextzugriff (PDF)

S35 Patients with triple negative breast cancer

Breast (Edinburgh), 2011, Vol.20, p.S13-S14

2011

Volltextzugriff (PDF)

Giredestrant for Estrogen Receptor-Positive, HER2-Negative, Previously Treated Advanced Breast Cancer: Results From the Randomized, Phase II acelERA Breast Cancer Study

Journal of clinical oncology, 2024-06, Vol.42 (18), p.2149

2024

Volltextzugriff (PDF)

293P Impact of tucatinib on progression free survival in patients with HER2+ metastatic breast cancer and stable or active brain metastases

Annals of oncology, 2020-09, Vol.31, p.S359-S360

2020

Volltextzugriff (PDF)

182MO Trastuzumab deruxtecan (T-DXd) vs treatment of physician’s choice (TPC) in patients (pts) with HER2+ metastatic breast cancer (mBC) previously treated with trastuzumab emtansine (T-DM1): Updated overall survival (OS) results of the randomized phase III DESTINY-breast (DB-)02 study

ESMO open, 2024-05, Vol.9, p.103204, Article 103204

2024

Volltextzugriff (PDF)

ES3-3: Adjuvant Therapy in Patients with a Borderline HER-2 Status

Cancer research (Chicago, Ill.), 2011-12, Vol.71 (24_Supplement), p.ES3-3-ES3-3

2011

Volltextzugriff (PDF)

Re: Topoisomerase II Alpha and Responsiveness of Breast Cancer to Adjuvant Chemotherapy

JNCI : Journal of the National Cancer Institute, 2009-12, Vol.101 (24), p.1735-1736

2009

Volltextzugriff (PDF)

A case of prostatitis due to Burkholderia pseudomallei

Nature clinical practice urology, 2007-02, Vol.4 (2), p.111-114

2007

Volltextzugriff (PDF)

Evaluation of the cardiovascular health study (CHS) instrument and the Vulnerable Elders Survey-13 (VES-13) in elderly cancer patients. Are we still missing the right screening tool?

Annals of oncology, 2013-02, Vol.24 (2), p.494

2013

Volltextzugriff (PDF)

The Lower Cretaceous plays of the Central and Northern North Sea: Atlantean drainage models and enhanced hydrocarbon potential

Geological Society, London, Petroleum Geology Conference Series, 2005-01, Vol.6 (1), p.187-198

OAKMAN, C. D.

2005

Volltextzugriff (PDF)

1 – 25 von 97

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(87)
Mit Volltextzugriff
(79)

Publikationsform

Sprache

Englisch
(97)

Erscheinungsjahr

n.n

Thema

Science & Technology
(50)
Life Sciences & Biomedicine
(44)
Humans
(40)
Female
(33)
Male
(28)
Adult
(20)
Middle Aged
(20)
Biological And Medical Sciences
(19)
Medical Sciences
(15)
Social Sciences
(15)
Psychiatry
(14)
Aged
(13)
Psychology
(13)
Psychology. Psychoanalysis. Psychiatry
(13)
Adolescent
(9)
Psychology, Clinical
(9)
Hematology, Oncology And Palliative Medicine
(8)
Oncology
(8)
Pharmacology. Drug Treatments
(8)
Environmental Sciences & Ecology
(7)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Understory Vegetation Responses to 15 Years of Repeated Fuel Reduction Treatments in the Southern Appalachian Mountains, USA

Identification of a serum-detectable metabolomic fingerprint potentially correlated with the presence of micrometastatic disease in early breast cancer patients at varying risks of disease relapse by traditional prognostic methods

19 Breast Cancer in the Elderly

Evaluation of the cardiovascular health study (CHS) instrument and the Vulnerable Elders Survey-13 (VES-13) in elderly cancer patients. Are we still missing the right screening tool?

225 INVITED EUSOMA Recommendations for the Management of Elderly Women With Breast Cancer

‘Aussie normals’: an a priori study to develop clinical chemistry reference intervals in a healthy Australian population

209 Can we select patients for adjuvant therapy based on the presence of micro-metastatic disease?

Overall survival benefit for sequential doxorubicin–docetaxel compared with concurrent doxorubicin and docetaxel in node-positive breast cancer—8-year results of the Breast International Group 02-98 phase III trial

Chemotherapy with or without trastuzumab

Understory community shifts in response to repeated fire and fire surrogate treatments in the southern Appalachian Mountains, USA

Posthurricane Salinity in an Impounded Coastal Wetland (Bayou Sauvage, Louisiana, U.S.A.)

762 Prognostic and Predictive Value of TP53 Mutations in Node-positive Breast Cancer Patients Treated with Anthracycline-or Anthracycline/taxane Based Adjuvant Therapy – Results From the BIG 02-98 Phase III Trial

Palbociclib in Hormone-Receptor–Positive Advanced Breast Cancer

Other targets beyond PARP for TN disease

S4 Did we learn more about adjuvant chemotherapy? The dark side of data from clinical trials

Preoperative investigations for metastatic staging of colon and rectal cancer across multiple centres - what is current practice?

S35 Patients with triple negative breast cancer

Giredestrant for Estrogen Receptor-Positive, HER2-Negative, Previously Treated Advanced Breast Cancer: Results From the Randomized, Phase II acelERA Breast Cancer Study

293P Impact of tucatinib on progression free survival in patients with HER2+ metastatic breast cancer and stable or active brain metastases

182MO Trastuzumab deruxtecan (T-DXd) vs treatment of physician’s choice (TPC) in patients (pts) with HER2+ metastatic breast cancer (mBC) previously treated with trastuzumab emtansine (T-DM1): Updated overall survival (OS) results of the randomized phase III DESTINY-breast (DB-)02 study

ES3-3: Adjuvant Therapy in Patients with a Borderline HER-2 Status

Re: Topoisomerase II Alpha and Responsiveness of Breast Cancer to Adjuvant Chemotherapy

A case of prostatitis due to Burkholderia pseudomallei

Evaluation of the cardiovascular health study (CHS) instrument and the Vulnerable Elders Survey-13 (VES-13) in elderly cancer patients. Are we still missing the right screening tool?

The Lower Cretaceous plays of the Central and Northern North Sea: Atlantean drainage models and enhanced hydrocarbon potential

Suchergebnisse filtern